menu
    • menu

    Company profile for Seer

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Seer is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights and breakthroughs in the understanding of biology and disease. Our novel Proteograph™ platform allows for the first-ever generation of proteomic information with high accuracy at a scale and speed not previously possible, complementing genomic and other health information, and with a goal of enabling resear...
    Seer is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights and breakthroughs in the understanding of biology and disease. Our novel Proteograph™ platform allows for the first-ever generation of proteomic information with high accuracy at a scale and speed not previously possible, complementing genomic and other health information, and with a goal of enabling research breakthroughs in the most challenging clinical problems, such as early disease detection.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SeerUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3800 Bridge Parkway, Suite 102, Redwood City, CA 94065
    Telephone
    Telephone
    +1-650-453-0000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://seer.bio/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/seer
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Seer Implements Tax Benefit Preservation Plan For Tax Asset
    Seer Implements Tax Benefit Preservation Plan For Tax Asset

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3246111/0/en/Seer-Adopts-Limited-Duration-Tax-Benefit-Preservation-Plan-to-Protect-its-Valuable-Tax-Assets.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Seer to Participate in TD Cowen Annual Health Care Conference
    Seer to Participate in TD Cowen Annual Health Care Conference

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240626/0/en/Seer-to-Participate-in-the-TD-Cowen-46th-Annual-Health-Care-Conference.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Seer To Release 2025 Financial Results On February 26, 2026
    Seer To Release 2025 Financial Results On February 26, 2026

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3233438/0/en/Seer-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-26-2026.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share
    Seer's Proteograph Platform Validated In Nature Genetics Study
    Seer's Proteograph Platform Validated In Nature Genetics Study

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196842/0/en/Nature-Genetics-Study-Validates-Seer-s-Proteograph-Platform-as-Essential-for-Turning-Genetic-Signals-Into-Reliable-Drug-Targets-and-Biomarkers.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Seer, Collaborators Showcase Deep Proteomics Impact At HUPO 2025
    Seer, Collaborators Showcase Deep Proteomics Impact At HUPO 2025

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183528/0/en/Seer-and-Collaborators-Unveil-Broad-New-Data-Demonstrating-the-Translational-Power-of-Deep-Proteomics-at-HUPO-2025.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Seer Reports Third Quarter 2025 Financial Results
    Seer Reports Third Quarter 2025 Financial Results

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183081/0/en/Seer-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search